171 related articles for article (PubMed ID: 27405757)
1. Controlling PTEN (Phosphatase and Tensin Homolog) Stability: A DOMINANT ROLE FOR LYSINE 66.
Gupta A; Leslie NR
J Biol Chem; 2016 Aug; 291(35):18465-73. PubMed ID: 27405757
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress.
Maccario H; Perera NM; Gray A; Downes CP; Leslie NR
J Biol Chem; 2010 Apr; 285(17):12620-8. PubMed ID: 20177066
[TBL] [Abstract][Full Text] [Related]
3. Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.
Yang JM; Schiapparelli P; Nguyen HN; Igarashi A; Zhang Q; Abbadi S; Amzel LM; Sesaki H; Quiñones-Hinojosa A; Iijima M
Oncogene; 2017 Jun; 36(26):3673-3685. PubMed ID: 28263967
[TBL] [Abstract][Full Text] [Related]
4. Analysis of PTEN ubiquitylation and SUMOylation using molecular traps.
Lang V; Aillet F; Da Silva-Ferrada E; Xolalpa W; Zabaleta L; Rivas C; Rodriguez MS
Methods; 2015 May; 77-78():112-8. PubMed ID: 25224693
[TBL] [Abstract][Full Text] [Related]
5. In Cell and In Vitro Assays to Measure PTEN Ubiquitination.
Gupta A; Maccario H; Kriplani N; Leslie NR
Methods Mol Biol; 2016; 1388():155-65. PubMed ID: 27033076
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer.
Wang K; Liu J; Li YL; Li JP; Zhang R
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188723. PubMed ID: 35314212
[TBL] [Abstract][Full Text] [Related]
7. Post-translational regulation of PTEN.
Wang X; Jiang X
Oncogene; 2008 Sep; 27(41):5454-63. PubMed ID: 18794880
[TBL] [Abstract][Full Text] [Related]
8. Poly-ADP ribosylation of PTEN by tankyrases promotes PTEN degradation and tumor growth.
Li N; Zhang Y; Han X; Liang K; Wang J; Feng L; Wang W; Songyang Z; Lin C; Yang L; Yu Y; Chen J
Genes Dev; 2015 Jan; 29(2):157-70. PubMed ID: 25547115
[TBL] [Abstract][Full Text] [Related]
9. PTEN level in tumor suppression: how much is too little?
Carracedo A; Alimonti A; Pandolfi PP
Cancer Res; 2011 Feb; 71(3):629-33. PubMed ID: 21266353
[TBL] [Abstract][Full Text] [Related]
10. SIPL1-facilitated PTEN ubiquitination contributes to its association with PTEN.
De Melo J; Lin X; He L; Wei F; Major P; Tang D
Cell Signal; 2014 Dec; 26(12):2749-56. PubMed ID: 25152374
[TBL] [Abstract][Full Text] [Related]
11. Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer.
Tsai YS; Jou YC; Tsai HT; Shiau AL; Wu CL; Tzai TS
Cancer Sci; 2019 Apr; 110(4):1208-1219. PubMed ID: 30719818
[TBL] [Abstract][Full Text] [Related]
12. The PTEN protein: cellular localization and post-translational regulation.
Leslie NR; Kriplani N; Hermida MA; Alvarez-Garcia V; Wise HM
Biochem Soc Trans; 2016 Feb; 44(1):273-8. PubMed ID: 26862215
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN.
Nakakido M; Deng Z; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Neoplasia; 2015 Apr; 17(4):367-73. PubMed ID: 25925379
[TBL] [Abstract][Full Text] [Related]
14. Focal adhesion kinase phosphorylates the phosphatase and tensin homolog deleted on chromosome 10 under the control of p110δ phosphoinositide-3 kinase.
Tzenaki N; Aivaliotis M; Papakonstanti EA
FASEB J; 2015 Dec; 29(12):4840-52. PubMed ID: 26251180
[TBL] [Abstract][Full Text] [Related]
15. Non-genomic loss of PTEN function in cancer: not in my genes.
Leslie NR; Foti M
Trends Pharmacol Sci; 2011 Mar; 32(3):131-40. PubMed ID: 21236500
[TBL] [Abstract][Full Text] [Related]
16. Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non-small-cell lung cancer.
Sun H; Ma H; Wang J; Xia L; Zhu G; Wang Z; Sun J; Chen Z
Tumour Biol; 2017 Jul; 39(7):1010428317709639. PubMed ID: 28714370
[TBL] [Abstract][Full Text] [Related]
17. Regulation and modulation of PTEN activity.
Naderali E; Khaki AA; Rad JS; Ali-Hemmati A; Rahmati M; Charoudeh HN
Mol Biol Rep; 2018 Dec; 45(6):2869-2881. PubMed ID: 30145641
[TBL] [Abstract][Full Text] [Related]
18. SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Lu W; Liu S; Li B; Xie Y; Izban MG; Ballard BR; Sathyanarayana SA; Adunyah SE; Matusik RJ; Chen Z
Oncogene; 2017 Mar; 36(10):1364-1373. PubMed ID: 27869166
[TBL] [Abstract][Full Text] [Related]
19. The deubiquitylase Ataxin-3 restricts PTEN transcription in lung cancer cells.
Sacco JJ; Yau TY; Darling S; Patel V; Liu H; Urbé S; Clague MJ; Coulson JM
Oncogene; 2014 Aug; 33(33):4265-72. PubMed ID: 24292675
[TBL] [Abstract][Full Text] [Related]
20. Na(+)/H(+) exchanger regulatory factor 1 (NHERF1) is required for the estradiol-dependent increase of phosphatase and tensin homolog (PTEN) protein expression.
Yang L; Wang Y; Chen P; Hu J; Xiong Y; Feng D; Liu H; Zhang H; Yang H; He J
Endocrinology; 2011 Dec; 152(12):4537-49. PubMed ID: 21990315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
